Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial
about
Intermittent preventive treatment for malaria in children living in areas with seasonal transmissionIntermittent preventive antimalarial treatment for children with anaemiaIntermittent preventive antimalarial treatment for children with anaemiaMass drug administration for malariaIron, anemia and hepcidin in malariaDeclining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western EthiopiaTwo strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trialIntermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trialDeterminants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenFacilitators and Barriers to Uptake of an Extended Seasonal Malaria Chemoprevention Programme in Ghana: A Qualitative Study of Caregivers and Community Health WorkersCost analysis of school-based intermittent screening and treatment of malaria in KenyaThe use of formative research to inform the design of a seasonal malaria chemoprevention intervention in northern NigeriaIntermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and deliveryIndependent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa.Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trialMorbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.Decline in childhood iron deficiency after interruption of malaria transmission in highland Kenya.Intermittent preventive treatment of malaria in children: a qualitative study of community perceptions and recommendations in Burkina Faso and Mali.A trial of intermittent preventive treatment and home-based management of malaria in a rural area of The Gambia.Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistanceEffects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in MaliAnalysis of Preventive Interventions for Malaria: Exploring Partial and Complete Protection and Total and Primary Intervention EffectsSeasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa.Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trialHaemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis.Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in MaliThe potential benefit of scaling up malaria prevention to reduce low birth weight in Africa.Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, UgandaPlasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR CongoSelective intermittent preventive treatment of vivax malaria: reduction of malaria incidence in an open cohort study in brazilian AmazonEstimating the potential public health impact of seasonal malaria chemoprevention in African children.Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal.Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.Monitoring antifolate resistance in intermittent preventive therapy for malaria.Longitudinal follow-up of malaria transmission dynamics in two villages in a Sahelian area of Niger during a nationwide insecticide-treated bednet distribution programme.Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis.Implications of malaria on iron deficiency control strategies.Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso.
P2860
Q21032527-F40B97C8-43C2-4804-BA73-067E6B0F25CFQ24186627-6C665ACF-86B4-4DEA-906A-B18458D6340CQ24197789-DEE7057A-1494-42BC-BF81-5BC3D393AC4CQ24201881-A6A92A05-3F5D-428E-B3A2-96CD046D70BFQ26828803-37159BC7-BA2C-4404-8CF8-8E14908FBA37Q28125927-650A57D8-10F7-4AEA-9A47-78892E751959Q28477047-5C2DFDE9-9A05-4699-BA9F-681DB2AF9574Q28477053-2C37E949-27BC-49DE-8162-141725B889BBQ28477679-A7DFA6FB-B065-4340-AFE6-6FCCC5D08952Q28554508-32968EA0-A1B9-4DF7-965D-A9B7B9876E04Q28744234-79493B21-7A67-4A50-ADCE-3C1A31B3B1A2Q30381724-7223DF09-44D1-4DC1-A218-88C7E0E52162Q33815505-CBE97677-BD30-4B0B-820D-27FD25EADDCEQ33816411-439B4DA1-9FC0-426B-8B94-BDC0A34AA1F4Q33964491-5152306B-6832-4FCE-AF08-22E3F31639AEQ33999551-9114676F-CCE4-4399-904F-CA598AC15F1AQ33999559-A7FBFDAA-1C95-4249-9F9F-5484D6D4CF31Q34056231-A49ACA61-7E52-48EE-B728-67556A54805AQ34193509-886E53DA-326B-4FD7-9547-AD05ED79A28CQ34506683-0BC162B3-5FB0-4CBE-84E0-344E6755D73DQ35005101-9E48E5BE-4C00-401A-8F29-BD614106BA84Q35398338-AA4D3A05-99C8-43BE-9678-A11E1C22FF4AQ35713083-3295935B-4B8F-4A00-90CD-D337190C3B95Q35748391-33E7F91A-9CA6-487B-8A83-921D656C7B9BQ35777352-B9CF8CBD-A966-4DE0-A58B-F12C80E00109Q36114619-689DBC6A-2F38-4466-96B4-7F2125A06091Q36143003-42ED802D-D9FC-4E5E-B523-201D3066D146Q36292794-92894788-8D64-4B63-8A92-9F63584AE9BBQ36552347-E151A414-5F90-41F2-9798-EA6AA779F7BDQ36572916-57C93740-26E9-4E0E-9506-3433F7AC3487Q36746327-435197D8-C9CA-430D-B109-3ED0D89B3272Q36752769-A6D5EB11-8A9D-4FD6-9D03-A6804DDD7B91Q36840090-6C457409-8ADE-431B-B773-8BD08CA61E55Q37169651-7E943B6D-2214-4913-BA1F-5AE0773A0E45Q37260585-F2AD4E4C-C1D7-4758-AB0A-2CDBA9F03D2CQ39155308-E21C06D2-F0DB-4012-96B6-DE15487F3D1DQ40098394-F7753E1E-9FDC-4390-AFC4-177D6465FBDDQ41990805-029FE37E-3CD7-4918-9061-7FBCD74A95A6Q43168332-9620A025-58F0-459E-865B-84D95548CD08Q47097299-B5C8ABBE-9B8A-4AF9-B046-DA9DE9CCEE11
P2860
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intermittent preventive treatm ...... lind, placebo-controlled trial
@ast
Intermittent preventive treatm ...... lind, placebo-controlled trial
@en
Intermittent preventive treatm ...... lind, placebo-controlled trial
@nl
type
label
Intermittent preventive treatm ...... lind, placebo-controlled trial
@ast
Intermittent preventive treatm ...... lind, placebo-controlled trial
@en
Intermittent preventive treatm ...... lind, placebo-controlled trial
@nl
prefLabel
Intermittent preventive treatm ...... lind, placebo-controlled trial
@ast
Intermittent preventive treatm ...... lind, placebo-controlled trial
@en
Intermittent preventive treatm ...... lind, placebo-controlled trial
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Intermittent preventive treatm ...... lind, placebo-controlled trial
@en
P2093
Abdoulbaki I Diallo
Diadier A Diallo
Gaoussou Santara
Halimatou Diawara
Intimbeye Tembine
Niawanlou Dara
Toumani Conaré
Yahia Dicko
Youssoufa Sidibe
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000407
P407
P50
P577
2011-02-01T00:00:00Z